CTD402’s ready-to-use manufacturing platform eliminates the 1-2 month delays inherent to autologous CAR-T therapies—delays that can be life-threatening for patients with rapidly progressive disease.

The inaugural competition surprisingly awarded two $100,000 grand prizes to address challenges in defining robust benchmarks for complex biology.

Spyre Therapeutics (SYRE) has strong technical momentum and is trading at a new 52 week high. ・SYRE maintains a 100% “Buy” ...

Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicines, today congratulates its scientific co-founder, Professor Chad A. Mirkin, on being awarded the ...

Scientists from Turkey have designed a next-generation implantable biosensor using genetically engineered E. coli for ...

Buffett's actions speak volumes. You won't find Warren Buffett spreading doom and gloom. That isn't his style. Buffett has ...

A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...

Based on a list compiled by the American Institute of Physics, UNG had 19 physics graduates in 2023-24. As impressive as ...

The microbe Pyrodictium abyssi is an archaeon—a member of what's known as the third domain of life—and an extremophile. It ...

Students at centers like BioTC in OKC and other locations are training to step into jobs that didn’t even exist a decade ago ...

Genetic engineering is moving from the lab bench into clinics, farms, and even family planning decisions, promising to change ...

With the advent of AI-powered protein design tools, protein-based therapeutics may no longer be constrained by the limits imposed by natural selection.